189 related articles for article (PubMed ID: 35549312)
1. DNA Methylation Urine Biomarkers Test in the Diagnosis of Upper Tract Urothelial Carcinoma: Results from a Single-Center Prospective Clinical Trial.
Territo A; Gallioli A; Diana P; Boissier R; Fontana M; Gaya JM; Sanguedolce F; Calderón J; Piana A; Fontanet S; Algaba F; Palou J; Breda A
J Urol; 2022 Sep; 208(3):570-579. PubMed ID: 35549312
[TBL] [Abstract][Full Text] [Related]
2. Prospective evaluation of the RT-PCR based urinary marker Bladder Epicheck® as a diagnostic tool in upper urinary tract tumor.
Palermo M; D'Elia C; Trenti E; Comploj E; Mian C; Schwienbacher C; Heidegger I; Clauser S; Pycha A; Vjaters E
Minerva Urol Nephrol; 2024 Apr; 76(2):195-202. PubMed ID: 38498297
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic value of Xpert® BC Detection, Bladder Epicheck®, Urovysion® FISH and cytology in the detection of upper urinary tract urothelial carcinoma.
Pycha S; Trenti E; Mian C; Schwienbacher C; Hanspeter E; Palermo M; Pycha A; Danuser H; D'Elia C
World J Urol; 2023 May; 41(5):1323-1328. PubMed ID: 36929411
[TBL] [Abstract][Full Text] [Related]
4. Upper urothelial tract high-grade carcinoma: comparison of urine cytology and DNA methylation analysis in urinary samples.
Pierconti F; Martini M; Fiorentino V; Cenci T; Racioppi M; Foschi N; Di Gianfrancesco L; Sacco E; Rossi E; Larocca LM; Bassi PF
Hum Pathol; 2021 Dec; 118():42-48. PubMed ID: 34582934
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic predictive value of the Bladder EpiCheck test in the follow-up of patients with non-muscle-invasive bladder cancer.
Trenti E; D'Elia C; Mian C; Schwienbacher C; Hanspeter E; Pycha A; Kafka M; Degener S; Danuser H; Roth S; Pycha A
Cancer Cytopathol; 2019 Jul; 127(7):465-469. PubMed ID: 31154670
[TBL] [Abstract][Full Text] [Related]
6. The Role of Bladder Epicheck Test In Follow-Up of Patients with Non-Muscle Invasive Bladder Cancer.
Ragonese M; Gianfrancesco LD; Palermo G; Pierconti F; Martini M; Foti M; Bassi P; Racioppi M
Clin Genitourin Cancer; 2022 Aug; 20(4):e271-e275. PubMed ID: 35871875
[TBL] [Abstract][Full Text] [Related]
7. Bladder Epicheck Test: A Novel Tool to Support Urothelial Carcinoma Diagnosis in Urine Samples.
Fiorentino V; Pizzimenti C; Franchina M; Rossi ED; Tralongo P; Carlino A; Larocca LM; Martini M; Fadda G; Pierconti F
Int J Mol Sci; 2023 Aug; 24(15):. PubMed ID: 37569864
[TBL] [Abstract][Full Text] [Related]
8. Novel urinary biomarkers ADXBLADDER and bladder EpiCheck for diagnostics of bladder cancer: A review.
Wolfs JRE; Hermans TJN; Koldewijn EL; van de Kerkhof D
Urol Oncol; 2021 Mar; 39(3):161-170. PubMed ID: 33376063
[TBL] [Abstract][Full Text] [Related]
9. Does urinary cytology have a role in haematuria investigations?
Tan WS; Sarpong R; Khetrapal P; Rodney S; Mostafid H; Cresswell J; Watson D; Rane A; Hicks J; Hellawell G; Davies M; Srirangam SJ; Dawson L; Payne D; Williams N; Brew-Graves C; Feber A; Kelly JD;
BJU Int; 2019 Jan; 123(1):74-81. PubMed ID: 30003675
[TBL] [Abstract][Full Text] [Related]
10. Fluorescence in situ hybridization (FISH) in the diagnosis of bladder and upper tract urothelial carcinoma: the largest single-institution experience to date.
Gomella LG; Mann MJ; Cleary RC; Hubosky SG; Bagley DH; Thumar AB; McCue PA; Lallas CD; Trabulsi EJ
Can J Urol; 2017 Feb; 24(1):8620-8626. PubMed ID: 28263126
[TBL] [Abstract][Full Text] [Related]
11. A Urine-based DNA Methylation Marker Test to Detect Upper Tract Urothelial Carcinoma: A Prospective Cohort Study.
Ghoreifi A; Ladi-Seyedian SS; Piatti P; Chew YC; Jara B; Sanossian L; Bhasin JM; Yamada T; Fuchs G; Bhanvadia S; Sotelo R; Hung A; Aron M; Desai M; Gill I; Daneshmand S; Liang G; Djaladat H
J Urol; 2023 May; 209(5):854-862. PubMed ID: 36795966
[TBL] [Abstract][Full Text] [Related]
12. DNA methylation analysis in urinary samples: A useful method to predict the risk of neoplastic recurrence in patients with urothelial carcinoma of the bladder in the high-risk group.
Pierconti F; Rossi ED; Cenci T; Carlino A; Fiorentino V; Totaro A; Sacco E; Palermo G; Iacovelli R; Larocca LM; Bassi PF; Martini M
Cancer Cytopathol; 2023 Mar; 131(3):158-164. PubMed ID: 36262084
[TBL] [Abstract][Full Text] [Related]
13. The combination cytology/epichek test in non muscle invasive bladder carcinoma follow-up: Effective tool or useless expence?
Pierconti F; Martini M; Fiorentino V; Cenci T; Capodimonti S; Straccia P; Sacco E; Pugliese D; Cindolo L; Larocca LM; Bassi PF
Urol Oncol; 2021 Feb; 39(2):131.e17-131.e21. PubMed ID: 32773233
[TBL] [Abstract][Full Text] [Related]
14. Performance of the Bladder EpiCheck™ Methylation Test for Patients Under Surveillance for Non-muscle-invasive Bladder Cancer: Results of a Multicenter, Prospective, Blinded Clinical Trial.
Witjes JA; Morote J; Cornel EB; Gakis G; van Valenberg FJP; Lozano F; Sternberg IA; Willemsen E; Hegemann ML; Paitan Y; Leibovitch I
Eur Urol Oncol; 2018 Sep; 1(4):307-313. PubMed ID: 31100252
[TBL] [Abstract][Full Text] [Related]
15. Methylation study of the Paris system for reporting urinary (TPS) categories.
Pierconti F; Martini M; Cenci T; Fiorentino V; Sacco E; Bientinesi R; Pugliese D; Iacovelli R; Schinzari G; Larocca LM; Bassi PF
J Clin Pathol; 2021 Feb; 74(2):102-105. PubMed ID: 32527754
[TBL] [Abstract][Full Text] [Related]
16. MRI for risk stratification of muscle invasion by upper tract urothelial carcinoma: a feasibility study.
Messina E; Proietti F; Laschena L; Flammia RS; Pecoraro M; Cipollari S; Simone G; Catalano C; Leonardo C; Panebianco V
Eur Radiol Exp; 2024 Jan; 8(1):9. PubMed ID: 38238523
[TBL] [Abstract][Full Text] [Related]
17. Xpert® bladder cancer detection as a diagnostic tool in upper urinary tract urothelial carcinoma: preliminary results.
D'Elia C; Trenti E; Krause P; Pycha A; Mian C; Schwienbacher C; Hanspeter E; Kafka M; Palermo M; Spedicato GA; Holl S; Pycha A
Ther Adv Urol; 2022; 14():17562872221090320. PubMed ID: 35450126
[TBL] [Abstract][Full Text] [Related]
18. Performance of Urinary Markers for Detection of Upper Tract Urothelial Carcinoma: Is Upper Tract Urine More Accurate than Urine from the Bladder?
Bier S; Hennenlotter J; Esser M; Mohrhardt S; Rausch S; Schwentner C; Maas M; Deininger S; Walz S; Bedke J; Stenzl A; Todenhöfer T
Dis Markers; 2018; 2018():5823870. PubMed ID: 29651327
[TBL] [Abstract][Full Text] [Related]
19. Urinary cytology has a poor performance for predicting invasive or high-grade upper-tract urothelial carcinoma.
Messer J; Shariat SF; Brien JC; Herman MP; Ng CK; Scherr DS; Scoll B; Uzzo RG; Wille M; Eggener SE; Steinberg G; Terrell JD; Lucas SM; Lotan Y; Boorjian SA; Raman JD
BJU Int; 2011 Sep; 108(5):701-5. PubMed ID: 21320275
[TBL] [Abstract][Full Text] [Related]
20. Comparison of 2 new real-time polymerase chain reaction-based urinary markers in the follow-up of patients with non-muscle-invasive bladder cancer.
Trenti E; Pycha S; Mian C; Schwienbacher C; Hanspeter E; Kafka M; Spedicato GA; Vjaters E; Degener S; Pycha A; D'Elia C
Cancer Cytopathol; 2020 May; 128(5):341-347. PubMed ID: 31977131
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
